fashion -WSS

fashion

author：entertainment 2025-10-01 17:06:08 - browse：8367

A follow-up study of a first-of-its-kind cancer treatment may reflect systemic biases, the Food and Drug Administration said ahead of an advisory committee meeting Thursday to determine whether the drug should remain on the market.

The treatment, Lumakras, is designed to treat lung cancer caused by a specific genetic mutation to a protein called KRAS. It’s one of the most common genetic mutations in cancer, but repeated clinical trial failures had led researchers to deem it “undruggable” until a glimmer of hope came about a decade ago.

Lumakras received an accelerated, or conditional, approval in May 2021, making it the first KRAS drug on the market. Now, the drug’s manufacturer, Amgen, needs to prove it works.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Cassava Sciences’ Alzheimer’s clinical trials should be halted

WSS

Health tech investors get more selective as pandemic boom fades

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

UnitedHealth, Optum discontinue NaviHealth name

OTC birth control: A brief history of over the counter pill design

Cassava Sciences’ Alzheimer’s clinical trials should be halted

explore

fashion

entertainment

Malaria cases in Florida and Texas: Here’s what you need to know

Nearly two

ChatGPT in medicine: STAT answers readers' burning questions

Roche acquires Telavant from Roivant, adding experimental IBD treatment

In Memoriam: Notable people who died in 2023

Study on Amgen’s bispecific immunotherapy produces positive data

Cancer drug shortages should be causing more outrage

Results on Novartis prostate cancer therapy could expand its use

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

My superpower is killing ticks

focus

Dramatically reducing cancer deaths requires the PASTEUR Act

FDA clears Verve to begin U.S. study of gene

Microsoft strikes partnership with Duke Health to advance health AI

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

Verily hires former Apple Health leader as chief scientific officer

UnitedHealth, Optum discontinue NaviHealth name

Wikipedia

Wikipedia

focus

Wikipedia